14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $47.62 $54.48 Monday, 22nd Apr 2024 BMY stock ended at $49.14. This is 0.429% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 1.41% from a day low at $48.87 to a day high of $49.56.
90 days $47.58 $55.03
52 weeks $47.58 $70.94

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Apr 22, 2024 $49.00 $49.56 $48.87 $49.14 7 643 978
Apr 19, 2024 $48.21 $49.05 $48.12 $48.93 8 086 805
Apr 18, 2024 $47.93 $48.41 $47.62 $48.30 10 190 483
Apr 17, 2024 $48.44 $48.55 $47.70 $47.84 11 313 933
Apr 16, 2024 $48.45 $48.60 $48.24 $48.26 10 352 873
Apr 15, 2024 $48.36 $49.10 $48.12 $48.51 9 957 517
Apr 12, 2024 $49.04 $49.09 $48.26 $48.28 11 799 939
Apr 11, 2024 $50.46 $50.58 $49.11 $49.12 11 345 119
Apr 10, 2024 $51.04 $51.29 $50.28 $50.29 9 364 354
Apr 09, 2024 $51.13 $51.68 $51.07 $51.60 6 477 341
Apr 08, 2024 $51.28 $51.30 $50.86 $51.10 7 020 686
Apr 05, 2024 $51.19 $51.45 $50.77 $51.32 9 085 610
Apr 04, 2024 $51.94 $52.09 $51.20 $51.40 7 954 293
Apr 03, 2024 $52.75 $52.87 $52.10 $52.18 8 344 617
Apr 02, 2024 $53.10 $53.35 $52.53 $52.74 8 132 200
Apr 01, 2024 $54.17 $54.22 $52.96 $52.99 9 513 543
Mar 28, 2024 $53.39 $54.48 $53.39 $54.23 9 401 351
Mar 27, 2024 $53.00 $53.69 $52.85 $53.25 12 223 919
Mar 26, 2024 $52.39 $52.65 $52.04 $52.55 9 529 830
Mar 25, 2024 $52.08 $52.74 $51.92 $52.25 8 793 294
Mar 22, 2024 $51.65 $52.45 $51.52 $51.93 7 928 249
Mar 21, 2024 $51.91 $52.65 $51.56 $51.59 12 558 770
Mar 20, 2024 $51.63 $52.16 $51.27 $51.88 6 529 098
Mar 19, 2024 $51.76 $51.93 $51.39 $51.80 14 541 407
Mar 18, 2024 $52.58 $52.70 $51.54 $51.59 11 798 980
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT